Postmenopause Clinical Trial
Official title:
Multicenter Non-interventional Study on Efficacy, Tolerability, and Acceptance of Wellnara Containing 1.03 mg Estradiol Hemihydrate (Equivalent to 1 mg Estradiol) and 0.04 mg Levonorgestrel for Treatment of Hormone Deficiency Symptoms in Postmenopausal Women During 6 Cycles of 28 Days.
Aim of this NIS is to obtain further information on efficacy, tolerability, and acceptance of Wellnara in a large user population under the conditions of routine medical practice. Furthermore, any adverse drug reactions will be recorded in a large user population under the conditions of medical routine. To investigate the efficacy of Wellnara, patients will fill in a questionnaire, the so-called Menopause Rating Scale (MRS II). Further, the effects of treatment on skin and hair will be evaluated by the investigator. Patients will assess treatment effects on their sexual life. Safety parameters include monitoring of vaginal bleeding, measurement of blood pressure and body weight, and - as far as routinely used in the practice - calculation of waist-hip-ratio. Any relevant additional information related to adverse drug reactions will also be documented.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05448079 -
The Effect of Sexual Counseling Given According to the PLISSIT Model on FSFI, MAS and SQOL-F of Postmenopausal Women
|
N/A | |
| Completed |
NCT00745173 -
Study Evaluating Premarin and Bazedoxifene Potential Interaction
|
Phase 1 | |
| Completed |
NCT00550433 -
Study Evaluating Bazedoxifene/CE in Postmenopausal Women
|
Phase 1 | |
| Completed |
NCT00381251 -
Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.
|
Phase 1 | |
| Completed |
NCT00515593 -
PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
|
N/A | |
| Completed |
NCT00185328 -
Efficacy and Tolerability of Angeliq in Thai Women
|
Phase 4 | |
| Completed |
NCT00484107 -
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women
|
Phase 4 | |
| Completed |
NCT00023543 -
Reduction of Triglycerides in Women on Hormone Replacement Therapy
|
Phase 2 | |
| Completed |
NCT00006407 -
Sex Steroid Hormones and Risk of CHD in Women
|
N/A | |
| Completed |
NCT00152282 -
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
|
Phase 2 | |
| Completed |
NCT00010712 -
Effects of Black Cohosh on Menopausal Hot Flashes
|
Phase 2 | |
| Completed |
NCT00006539 -
Thrombotic, Inflammatory & Gene Markers of CVD in Women
|
N/A | |
| Completed |
NCT00001752 -
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
|
Phase 2 | |
| Completed |
NCT00005515 -
Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
|
N/A | |
| Completed |
NCT00000481 -
Women's Health Trial: Feasibility Study in Minority Populations
|
Phase 3 | |
| Completed |
NCT00000466 -
Postmenopausal Estrogen/Progestin Interventions (PEPI)
|
Phase 3 | |
| Completed |
NCT00543634 -
Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
|
Phase 1 | |
| Completed |
NCT06115577 -
Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes
|
||
| Completed |
NCT01556737 -
Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women
|
N/A | |
| Completed |
NCT00455741 -
Postmenopausal Women Estrogen and Progesterone Infusion
|
Phase 1/Phase 2 |